title: Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics.
authors.affiliation: Vanderbilt Orthopedic Trauma, Medical Center East-South Tower, Suite 4200, Nashville, TN 37232-8774, USA. william.obremskey@vanderbilt.edu
authors.forename: William T
authors.initials: WT
authors.lastname: Obremskey
authors.forename: James S
authors.initials: JS
authors.lastname: Marotta
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Yaszemski
authors.forename: Larry R
authors.initials: LR
authors.lastname: Churchill
authors.forename: Scott D
authors.initials: SD
authors.lastname: Boden
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Dirschl
mesh_terms: D001688:Biological Products / Q000191:economics; D019485:Bone Morphogenetic Proteins / Q000191:economics / Q000494:pharmacology*; D003132:Commerce; D017277:Drug Approval; D006801:Humans; D009985:Orthopedics / Q000191:economics / Q000941:ethics; D053657:Platelet-Rich Plasma; D010983:Plateletpheresis / Q000191:economics / Q000941:ethics / Q000295:instrumentation*; D013673:Technology Assessment, Biomedical; D014481:United States
chemical_list: D001688:Biological Products; D019485:Bone Morphogenetic Proteins